The FDA's ANDA process lets generic drug makers prove their products are equivalent to brand-name drugs without repeating costly clinical trials. This system saves billions annually and makes 90% of U.S. prescriptions affordable.
Read MoreThe FDA's ANDA process lets generic drug makers prove their products are equivalent to brand-name drugs without repeating costly clinical trials. This system saves billions annually and makes 90% of U.S. prescriptions affordable.
Read More